Collection 

Intravascular imaging in coronary artery disease

Submission status
Open
Submission deadline

Intravascular imaging methods, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS), have revolutionized our understanding of coronary pathophysiology and plaque characteristics. This themed collection aims to explore the role of intravascular imaging techniques, artificial intelligence (AI), and treatment strategies in understanding and managing coronary artery disease, with a particular focus on acute coronary syndrome (ACS) and vulnerable plaque. AI algorithms and machine learning techniques have shown tremendous potential in optimizing the analysis of intravascular imaging data. They have the potential to automate plaque characterization, plaque burden, and identify high-risk features, aiding the detection and risk stratification of vulnerable plaques.

This collection seeks to bring together original research, review articles, and case reports that delve into the diagnostic and prognostic value of intravascular imaging, AI applications, and new treatment strategies in ACS, with a special emphasis on the mechanisms (rupture, erosion, calcified nodule, SCAD, spasm, and others) assessment, imaging-guided personalized treatment, the identification and management of vulnerable plaques. The collection will highlight advancements in imaging modalities ( integration of emerging imaging modalities, such as photoacoustic imaging and intravascular magnetic resonance imaging, NIRS, and NIRF) and AI algorithms, shedding light on emerging approaches that may further enhance our ability to detect and treat high-risk plaques, providing a comprehensive overview of the current state of intravascular imaging, AI, and treatment of vulnerable plaque, this collection aims to foster knowledge exchange and drive future research in this exciting and promising field.

Submit manuscript
Manuscript editing services
Doctor using Intravascular ultrasound imaging (IVUS) machine at cardiac catheterization laboratory room.

Editors

  • Haibo Jia, MD, PhD, FACC, FESC

    Professor of Medicine, Interventional Cardiologist Vice President of The Second Affiliated Hospital of Harbin Medical University PI at National Key Laboratory of Frigid Zone Cardiovascular Diseases (NKLFZCD)

Dr. Haibo Jia, MD, PhD, FACC, FESC, Harbin Medical University & National Key Laboratory of Frigid Zone Cardiovascular
Diseases, China

Haibo Jia obtained his Master’s degree and PhD from Harbin Medical University. He completed his post-doctoral training at Harvard Medical School from 2012 to 2015. His clinical and academic abilities have been recognised through several awards, including ‘China’s Top Doctor Award 2018’ and National prize for progress in Science in Technology in 2019. Dr. Jia leads several clinical studies, focusing on acute coronary syndrome & specifically plaque erosion. His research works to elucidate the important role of plaque erosion and plaque rupture in the pathogenesis of acute coronary syndrome (ACS). His group established the optical coherence tomography (OCT) definitions of plaque erosion and calcified nodule in vivo. The EROSION serial studies have highlighted the potential for avoidance of stenting in ACS caused by plaque erosion. His ongoing research provides an opportunity to better delineate the drivers of this important cause of ACS, aiming to further influence treatment of these high-risk patients.